# Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication

> **NCT02868190** · PHASE4 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 57 (actual)

## Conditions studied

- Open Angle Glaucoma

## Interventions

- **DEVICE:** Two trabecular micro-bypass stents (iStent inject)

## Key facts

- **NCT ID:** NCT02868190
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2019-11-08
- **Final completion:** 2019-11-08
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02868190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02868190, "Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02868190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*